- FDA acting chief walks back Makary's practice of policymaking through journalsThe FDA is continuing to rewind actions by former Commissioner Marty Makary, saying that two medical journal articles published over the last year did not constitute agency policy. The about-face f…Endpoints · 13d ago↗ source
- Senate committee questions CDC pick on political interference over vaccinesLawmakers in the Senate pressed the Trump administration’s nominee for CDC director on whether she will cave to political pressure during a confirmation hearing on Wednesday. The CDC has been witho…Endpoints · 13d ago↗ source
- J&J restructures pharma manufacturing footprint at cost of up to $750MJohnson & Johnson is anticipating as much as $750 million in costs to restructure its pharmaceutical supply chain and exit factories, moves that are coming as it pushes ahead with its $55 billion p…